Hsin‐I Chang
- Biomaterials top 2%
- Molecular Biology
- Biomedical Engineering top 10%
- Pharmaceutical Science top 2%
- Surgery
- Co-authors
- Cheng‐Nan ChenAllan G.A. CoombesYiwei WangA.G.A. CoombesShun‐Fu ChangMong LiangCheng YanKo‐Chao Lee
- Topics
- Osteoarthritis Treatment and Mechanisms (7 papers)Nanoparticle-Based Drug Delivery (6 papers)Advanced Drug Delivery Systems (6 papers)
- Partner nations
- TaiwanAustraliaUnited Kingdom
In The Last Decade
Hsin‐I Chang
47 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Biomaterials 599
- Molecular Biology 521
- Biomedical Engineering 383
- Pharmaceutical Science 180
- Surgery 123
Countries citing papers authored by Hsin‐I Chang
This map shows the geographic impact of Hsin‐I Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐I Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐I Chang more than expected).
Fields of papers citing papers by Hsin‐I Chang
This network shows the impact of papers produced by Hsin‐I Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐I Chang. The network helps show where Hsin‐I Chang may publish in the future.
Co-authorship network of co-authors of Hsin‐I Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Hsin‐I Chang. A scholar is included among the top collaborators of Hsin‐I Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin‐I Chang. Hsin‐I Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 27 | |
| 6 | 4 | |
| 7 | 20 | |
| 8 | 46 | |
| 9 | 16 | |
| 10 | 15 | |
| 11 | Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacybreakdown → | 653 |
| 12 | Relationship between the Antiplatelet Effect of Aspirin and Serum VCAM-1 Concentration in Patients at High Risk for Cardiovascular Events | 4 |
| 13 | 38 | |
| 14 | 24 | |
| 15 | Characterizing Microporous PCL Matrices for Application of Tissue Engineering | 17 |
| 16 | 16 | |
| 17 | 21 | |
| 18 | 46 | |
| 19 | 38 | |
| 20 | 29 |
About Hsin‐I Chang
Hsin‐I Chang is a scholar working on Pharmaceutical Science, Biomaterials and Immunology and Allergy, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). The work is most often cited by research in Biomaterials (599 citations), Pharmaceutical Science (180 citations) and Rehabilitation (74 citations). Hsin‐I Chang has collaborated with scholars based in Taiwan, Australia and United Kingdom. Frequent co-authors include Cheng‐Nan Chen, Allan G.A. Coombes, Yiwei Wang, A.G.A. Coombes, Shun‐Fu Chang, Mong Liang, Cheng Yan, Ko‐Chao Lee, Kuo‐Yuan Huang and Allan S. Jones. Their work appears in journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Climate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.